recombinant human il-15 Search Results


il 15  (Gold Biotechnology Inc)
93
Gold Biotechnology Inc il 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Il 15, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 15/product/Gold Biotechnology Inc
Average 93 stars, based on 1 article reviews
il 15 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
recombinant human il 15  (R&D Systems)
90
R&D Systems recombinant human il 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Recombinant Human Il 15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il 15/product/R&D Systems
Average 90 stars, based on 1 article reviews
recombinant human il 15 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human il 15  (R&D Systems)
93
R&D Systems human il 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Human Il 15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 15/product/R&D Systems
Average 93 stars, based on 1 article reviews
human il 15 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
interleukin 15  (Miltenyi Biotec)
94
Miltenyi Biotec interleukin 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Interleukin 15, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interleukin 15/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
interleukin 15 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
247 ilb  (R&D Systems)
95
R&D Systems 247 ilb
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
247 Ilb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/247 ilb/product/R&D Systems
Average 95 stars, based on 1 article reviews
247 ilb - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
gmp  (R&D Systems)
92
R&D Systems gmp
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Gmp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gmp/product/R&D Systems
Average 92 stars, based on 1 article reviews
gmp - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
recombinant human interleukin 15  (R&D Systems)
93
R&D Systems recombinant human interleukin 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Recombinant Human Interleukin 15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human interleukin 15/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant human interleukin 15 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
il 15  (R&D Systems)
94
R&D Systems il 15
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Il 15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 15/product/R&D Systems
Average 94 stars, based on 1 article reviews
il 15 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
recombinant mouse pd 1 human fc fusion protein  (R&D Systems)
92
R&D Systems recombinant mouse pd 1 human fc fusion protein
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Recombinant Mouse Pd 1 Human Fc Fusion Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse pd 1 human fc fusion protein/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant mouse pd 1 human fc fusion protein - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
bt 015 01m gm csf r d systems  (R&D Systems)
93
R&D Systems bt 015 01m gm csf r d systems
Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail <t>(IL-2,</t> <t>IL-15,</t> anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.
Bt 015 01m Gm Csf R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt 015 01m gm csf r d systems/product/R&D Systems
Average 93 stars, based on 1 article reviews
bt 015 01m gm csf r d systems - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail (IL-2, IL-15, anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.

Journal: Nature Biotechnology

Article Title: Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins

doi: 10.1038/s41587-022-01456-2

Figure Lengend Snippet: Representative flow cytometry showing presence of CD8 + T cell activation markers, a , PD-1 or b , CD25, following 4 day incubation with activation cocktail (IL-2, IL-15, anti-CD3, anti-CD28). c , Representative flow demonstrating cell surface PD-1 degradation on activated primary human CD8 + T cells following 24 hr treatment with 100 nM CXCL12-Nivo or nivolumab isotype.

Article Snippet: Following CD8 + T cell isolation, cells were stimulated with recombinant IL-2 (GoldBio) and IL-15 (GoldBio) and ImmunoCult Human CD3/CD28 T cell Activation (STEMCELL Technologies) for 4 d at 37 °C.

Techniques: Flow Cytometry, Activation Assay, Incubation